Skip to content
HowShorted

Viridian Therapeutics, Inc.\DE short interest in 2019

In 2019, Viridian Therapeutics, Inc.\DE's disclosed short interest ran from 2.72% of shares outstanding on 15 Oct 2019 to 1.80% on 31 Dec 2019, a change of -0.92 percentage points. The year's high was 2.72% on 15 Oct 2019 and its low 1.80% on 31 Dec 2019, averaging 2.22% across 6 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 7.61 days on 15 Oct 2019. Full history: Viridian Therapeutics, Inc.\DE.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Viridian Therapeutics, Inc.\DE in 2019

2019 in figures

Start of year
2.72% (15 Oct 2019)
End of year
1.80% (31 Dec 2019)
Change
-0.92 pp
High
2.72% (15 Oct 2019)
Low
1.80% (31 Dec 2019)
Average
2.22%
Highest days to cover
7.61 (15 Oct 2019)
SEC filings marked
8

Every report in 2019

Viridian Therapeutics, Inc.\DE short interest in 2019
SettlementShort interestDays to coverFilings since previous
15 Oct 20192.72%7.61results (8-K), 10-K filed, results (8-K), 10-Q filed, results (8-K), 10-Q filed
31 Oct 20192.61%2.95
15 Nov 20192.15%4.53results (8-K), 10-Q filed
29 Nov 20192.04%1.94
13 Dec 20192.02%1.52
31 Dec 20191.80%1.16

See also: Viridian Therapeutics, Inc.\DE's full history · most shorted US stocks of 2019 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.